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Abstract 
In 26 stable patients with chronic obstructive pulmonary disease, tidal expiratory flow 
limitation (TEFL), inspiratory capacity, breathing pattern and dyspnea sensation were assessed 
during air and heliox (20% O2 in He) breathing at rest and during exercise up to 2/3 maximal work 
rate. Breathing air, the 13 patients with TEFL at rest remained flow-limited also during exercise, 
while 7 of the non flow-limited patients became flow-limited; tidal volume increased more in non 
flow-limited patients, whereas inspiratory capacity decreased in flow-limited and increased in the 
non flow-limited patients. Heliox did not abolish flow limitation, had no effect on breathing pattern, 
reduced exercise dynamic hyperinflation in 25% of the flow-limited patients, depending on the 
degree of the dynamic hyperinflation on air, and lessened dyspnea sensation in all patients. Hence, 
presence of TEFL has no systematic effects on the respiratory response to heliox, and the heliox-




In COPD patients, helium-oxygen mixtures (heliox) have been and are still being used on 
the presumption that if turbulent flow occurs during tidal breathing, airway resistance would 
decrease, and flow, tidal volume, and inspiratory capacity increase, thus improving the efficiency of 
the respiratory performance and, as a consequence, the working capacity. Results obtained both at 
rest and during exercise are, however, contradictory. 
 At rest, a decrease in pulmonary resistance with heliox administration but no effect on 
dynamic hyperinflation was observed in COPD patients by Grapé et al. (1960), whereas no change 
in total respiratory resistance but an increase in inspiratory capacity was found by Wouters et al. 
(1992) and Swida et al. (1985), respectively. These discrepancies could be related to the occurrence 
of expiratory flow limitation with its different mechanisms. In fact, Meadows et al. (4) found that 
only half of their COPD patients performing an expiratory forced vital capacity maneuver, exhibited 
an increase in maximal expiratory flows with heliox. Three recent studies have failed, however, to 
show any effect (Pecchiari et al., 2004; Palange et al., 2004; Eves et al., 2006). During muscular 
exercise, heliox administration has been found to be beneficial in COPD patients in terms of 
symptoms and exercise capacity (Palange et al., 2004; Laude et al., 2006; O’Donnell et al., 2007). 
This favorable effect of heliox has been attributed to increased maximal ventilation and tidal 
volume at peak exercise, and reduction in dynamic hyperinflation at iso-time (Palange et al., 2004; 
Eves et al., 2006). In contrast, no significant effects were found by other studies (Raimondi et al., 
1970; Bradley et al., 1980; Oelberg et al., 1998; Johnson et al., 2002). 
 These contrasting respiratory responses could reflect differences among studies in the 
preponderance of flow-limited COPD patients, and nature of the expiratory flow-limitation, i.e the 
viscous or the density dependent wave speed mechanism. Since heliox does not lessen dynamic 
hyperinflation of resting flow-limited patients (Pecchiari et al., 2004), its effects should be minor 
also during exercise if flow-limitation were still due to the viscous, density independent mechanism. 
In non flow-limited patients, however, heliox could improve the respiratory performance by 
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lessening airway resistance, increasing maximal flows, and lowering end-expiratory lung volume. 
Indeed, normal subjects increase pulmonary ventilation and inspiratory capacity with heliox at 
higher work loads, when high flows are achieved and functional residual capacity increases while 
breathing air (Babb, 1997a; 1997b; McClaran et al., 1999). The present study has, therefore, 
compared the ventilatory response to heliox administration in expiratory flow-limited or non flow-
limited COPD patients both at rest and during normal, non-fatiguing physical activities. 
 
2. Methods 
Twenty-six, stable COPD patients were studied. Patients had no cardiovascular and other 
pulmonary diseases, nor upper respiratory tract infections during the previous month, and none was 
being treated with oral 2-agonists, theophylline or systemic corticosteroids, or had received 
inhaled short-acting 2-agonistic or anticholinergic drugs for 8 h or long-acting 2-agonists for 24 h 
before the study. The study was approved by the local Ethics Committee and by CCT 
(ISRCTN15098442). Informed consent was obtained from all patients. 
 Pulmonary function was assessed with standard methods and procedures (Quanier, 1983), 
using a body plethysmograph (Elite Series; MedGraphics, Saint Paul, MN) and reference values 
from Quanier (1983). Predicted values of inspiratory capacity (IC) were computed as difference 
between predicted total lung (TLC) and functional residual capacity (FRC). Arterial oxygen and 
carbon dioxide partial pressure and pH were measured with ABL 700 (Radiometer, Copenhagen, 
Denmark). Chronic dyspnea was evaluated using the modified Medical Research Council (MRC) 
scale (Eltayara et al., 1996). 
 In preliminary sessions, the patients, breathing ambient air, performed an incremental 
exercise test on a cycle ergometer (LODE; Medical Technology, Groningen Holland) to assess 
maximal oxygen consumption ( V O2peak) and work rate ( W max). V O2 was measured with Vmax 
29c (Sensor Medics, Yorba Linda, CA), using reference values from Wasserman et al. (1986). 
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Patients who felt uncomfortable with the breathing circuit or exercising at 2/3 W max fatiguing, 
were excluded from the study. 
In a subsequent session, the patients were investigated in the afternoon while breathing air 
and 10 min after equilibration with heliox (20% O2-80% He), both at rest and exercising at 1/3 and 
2/3 W max for 6-8 min at each work level, measurements being taken when a quasi-steady 
breathing pattern had established. The test sequence was randomized. About one hour elapsed 
between air and heliox tests, patients being kept unaware of the gas mixture breathed. The 
equipment has been described previously (Pecchiari et al., 2004). The pneumotachograph, 
calibrated with air or heliox, was linear over the experimental flow range. The equipment resistance 
(cmH2OsL
-1) was 0.72+0.07 V  on air and 0.63+0.03 V

 on heliox. The digitized flow signal was 
analyzed (LabVIEW; National Instruments, Austin, TX) to obtain tidal volume (VT), inspiratory 
(TI) and expiratory duration (TE), and pulmonary ventilation ( V I), besides IC. The 
electrocardiogram (Cardio Soft; Sensor Medics, Yorba Linda, CA) and oxygen saturation (8500M-
Pulseoximeter; Nonin Medical Inc., Plymouth, MN) were continuously recorded, the latter being 
>90%. Perceived breathlessness was assessed using the Borg 10-point scale.  
Both at rest and during exercise while breathing room air or heliox, 4-6 negative expiratory 
pressure (NEP) tests were performed, followed by maximal inspirations to assess IC, a reliable and 
commonly used procedure (Yan et al., 1997; Diaz et al., 2000; Dolmage and Goldstein, 2002). 
Patients were classified as non flow-limited if the expiratory flow with NEP increased over the 
entire control VT.  
Data, presented as mean ± SD, were analyzed using SPSS 11.5 (SPSS Inc., Chicago, IL). 
Significance of changes under various conditions was assessed using two-way ANOVA, with 
Bonferroni correction when required. Correlation between variables was evaluated from 





Table 1 shows the anthropometric characteristics and baseline lung function data of patients 
with or without tidal expiratory flow-limitation (TEFL) at rest. The anthropometric characteristics 
were similar in both groups. Flow-limited patients exhibited greater respiratory resistance, with 
significantly lower PEF, FEV1, and FEV1/FVC %pred., and were relatively hyperinflated, with 
significantly greater FRC and lower IC and FVC %pred.. No significant differences occurred 
between patients with or without TEFL in breathing pattern, arterial blood gasses and pH, which 
were in the normal range (Table 2).  
MRC score was similar in both groups, and correlated with IC and FEV1/ FVC %pred.; 
presence of TEFL correlated with several variables, the strongest correlation being with IC %pred., 
as for MRC score (Table 3). With stepwise regression analysis, IC was selected as the only 
significant predictor of TEFL. 
3.1 Effects of exercise 
In flow-limited and non flow-limited patients at rest, W max averaged 91±22 and 112±36 watt, 
respectively; corresponding values of V
 O2peak, %pred. were 66±14 and 80±16% (P=0.03). 
While breathing air, patients with TEFL at rest remained flow-limited also during exercise. 
Of the 13 non flow-limited patients at rest, 4 and 7 became flow-limited at the lower and higher 
work level, respectively. The changes of breath timing never differed significantly between patients 
with and without TEFL, whereas at 2/3 W max, VT, mean expiratory flow, and V I changes became 
significantly larger in non flow-limited patients (Table 4). 
While breathing heliox, the effects of exercise were qualitatively similar to those observed 
while breathing air both in patients with and without TEFL: the changes of breath timing never 
differed significantly between these patients, whereas at 2/3 W max, those of VT and V I became 
significantly larger in non flow-limited patients (Table 5). 
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At both exercise levels, IC decreased in flow-limited but increased in non flow-limited 
patients both during air (Table 4) and heliox breathing (Table 5). When end-expiratory (EELV) and 
end-inspiratory volume (EILV) were expressed as percent TLC, it appeared that with increasing the 
work rate the flow-limited patients were using most of their IC, in spite of smaller VT’s than non 
flow-limited patients, independent of the mixture breathed (Fig. 1, upper and middle panels). 
 Dyspnea was essentially absent at rest, but present during exercise, becoming significantly 
greater in flow-limited patients at the higher work level both on air (Table 4) and heliox (Table 5).  
3.2 Heliox vs air breathing 
In no instance did heliox abolish TEFL. Furthermore, shifting from air to heliox breathing 
had no significant effects on the breathing pattern and IC, both at rest and during exercise (Table 6). 
Indeed, when data from both flow-limited and non flow-limited patients obtained at rest or at a 
given exercise level were pooled, the operating lung volumes were independent of the mixture 
breathed (Fig. 1, lower panel). 
Though not influential on the overall behavior, exercise IC increased significantly with 
heliox in 3 of the 13 patients flow-limited at rest (ΔIC=0.15±0.03 L), in 2 of the 7 patients who 
became flow-limited with exercise (ΔIC=0.17±0.05 L), and in 1 of the 6 patients who were always 
non flow-limited (ΔIC=0.22±0.04 L). On the other hand, IC decreased significantly in one non 
flow-limited patient (ΔIC=-0.22±0.03 L). It should be noted that the breath-by-breath variation of 
EELV averaged 0.09±0.06 L (range: 0.05-0.12 L), independent of TEFL and work rate. 
Heliox lessened exercise dyspnea in both groups of patients, the reduction being significant 
only at 2/3 W max (Table 6). At this work rate, the changes in Borg score were -2±1.4, -2.3±2.9, 
and –1.2±0.8 in 15 flow-limited patients who did not change IC with heliox, 5 flow-limited patients 
who increased IC with heliox, and 6 non flow-limited patients, respectively, these values being not 




 This is the first study that addresses the role of tidal expiratory flow limitation in the 
response to exercise and heliox breathing of mild to moderate COPD patients. Its main finding is 
that the ventilatory response to non-fatiguing exercises differs between expiratory flow-limited and 
non flow-limited patients, whereas heliox has no systematic effects on breathing pattern and 
dynamic hyperinflation independent of TEFL, but lessens exercise dyspnea. 
Because of the aim of the study, consecutive expiratory flow-limited and non flow-limited 
patients were enrolled in the same number, eliminating those patients who felt breathing through the 
mouthpiece uncomfortable and/or those who were fatiguing. Although the present patients might 
not be, therefore, a typical sample of the COPD population, both the differences between flow-
limited and non flow-limited patients at rest and the dependencies of MRC score (Tables 1 and 3) 
are in agreement with previous observations made on a larger number of unselected COPD patients 
(Pecchiari et al., 2004; Diaz et al., 2000; 2001). The present results also show that IC, % pred. is the 
only significant predictor of the presence of TEFL at rest and/or during exercise (Table 3), and with 
the caution due to the small number of patients, individual data suggest that a resting value of IC 
>80% would ensure a >90% probability that a patient remains non flow-limited at least up to 
2/3 W max. 
While breathing ambient air at rest, the breathing pattern was independent of TEFL (Table 
2), in line with previous observations (Pecchiari et al., 2004; Diaz et al., 2001). During exercise, 
only VT increased more in non flow-limited patients, accounting for the greater changes in V I 
(Table 4). These differences were in part due to the work rate being expressed relative to individual 
W max. However, when the work rate was expressed in absolute terms, the slope of the ΔVT- W  
relationship was still significantly lower in flow-limited than non flow-limited patients (6.4±0.6 vs 
8.7±0.6 ml/watt; P<0.016), indicating that exercising patients with TEFL do increase their tidal 
volume less than non flow-limited patients independent of work rate, likely because of the 
concomitant dynamic hyperinflation. IC increased in non flow-limited patients, as it occurs in 
normal subjects (Babb, 1997a; 1997b; McClaran et al., 1999), but decreased in flow-limited patients 
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(Table 4), accounting for the smaller VT’s attained by these patients, the relative increase of EILV 
being similar in both groups of patients (Fig. 1). The increase in operating lung volumes is in fact 
the main mechanism whereby in flow-limited patients expiratory flow can be increased, TE 
shortened and yet VT augmented, allowing for higher V I. An additional mechanism is probably 
represented by the fall in airway resistance with exercise (Raimondi et al., 1970; Warren et al., 
1984). In contrast, in the non flow-limited patients about 25% of the increase in VT was due to the 
fall of EELV (Fig. 1). 
While breathing heliox, the changes of breathing pattern and IC with exercise were 
qualitatively similar to those observed while breathing air in the flow-limited and non flow-limited 
patients, respectively (Table 5). Indeed, heliox had no effect on the breathing pattern at rest or 
during exercise (Table 6). While heliox can increase exercise ventilation in subjects with normal 
pulmonary function and TEFL during exercise, though not assessed with the NEP technique 
(McClaran et al., 1999; Babb, 2001), no such an effect is seen in COPD patients when comparisons 
are made using present and published data (Raimondi et al., 1970; Bradley et al., 1980; Babb, 
1997b; Palange et al., 2004) obtained under the same conditions, including time from the onset of 
exercise. Furthermore, the present results indicate that absence of changes in the breathing pattern 
with heliox is independent of TEFL and IC changes (Table 6). 
At rest, heliox had no effect on the end-expiratory lung volume, independent of TEFL 
(Table 6 and Fig. 1). Similar results have been obtained in a previous study (Pecchiari et al., 2004) 
and in resting COPD patients in whom TEFL was not assessed (Palange et al., 2004; Eves et al., 
2006). Given the prevalence of TEFL in COPD patients (Koulouris et al., 1997; Diaz et al., 2000; 
Pecchiari et al., 2004), the results of the latter studies also indicate that heliox has no effect on 
resting IC independent of TEFL. Because during quite breathing, like passive expiration, heliox can 
increase maximal expiratory flows and reduce IC only if the flow-limiting segment were located in 
the central airways (Brighenti et al., 2007), all these results indicate that at rest TEFL is due usually 
to mechanical alterations of peripheral airways. It should be, therefore, expected that in patients 
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who are flow-limited at rest, heliox would not affect IC during exercise, as generally seen in the 
present study, as well as in normal subjects who become flow-limited during sub-maximal exercise 
(Babb, 2001).  
At variance with the present results obtained during non-fatiguing exercises, heliox has been 
shown to increase mean IC of exercising COPD patients at the time of exhaustion during room air 
breathing without affecting the breathing pattern (Palange et al., 2004; Eves et al., 2006). This 
discrepancy is not accounted for by differences in the severity of the disease, as assessed from 
common pulmonary function tests, or relative intensity of the exercise, but it could depend on the 
conditions in which measurements were performed causing different degrees of dynamic 
hyperinflation and location of the flow-limiting segment. Indeed, heliox has no effect in non flow-
limited patients in whom exercise IC increases during air breathing (Tables 5 and 6, and Fig. 1 and 
2), as it happens in normal non flow-limited subjects (Babb, 1997a; 1997b; McClaran et al., 1999), 
while in the absence of VT and TE changes (Table 6; Palange et al., 2004; Eves et al., 2006), the 
effect of heliox on IC must reflect the location of the flow-limiting segment. In patients with TEFL, 
an increase of IC can occur only if the flow-limiting segment moves with exercise from the 
peripheral to the central airways, thus allowing for increased maximal expiratory flows, as it 
happened in some patients flow-limited at rest, and in the majority of those studied by Palange et al. 
(2004) and Eves et al. (2006). This shift should in turn depend primarily on the increase in EELV 
which takes place during exercise while breathing air. Indeed, a) a significant negative correlation is 
observed in the present flow-limited patients between the decrease in IC with exercise while 
breathing ambient air and the subsequent changes caused by heliox (Fig. 2); and b) the decrease in 
IC during air breathing is substantially greater in Palange (-0.27 L) and Eves patients (-0.84 L, 
9.3%TLC) than in the present flow-limited patients (-0.18 L, 2.6%TLC). 
The present results do not allow the identification of the functional characteristics that 
distinguish the flow-limited COPD patients who, during exercise on air, increase their EELV 
sufficiently to move the choke point from the peripheral to the central airways, thus accounting for 
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the increase in IC while breathing heliox. Indeed, none of the variables measured at rest (Table 1 
and 2) differed significantly between the 20 flow-limited patients who did not increase exercise IC 
on heliox (non-responders) and the 5 flow-limited patients who did so (responders). Based on a 
model study (Brighenti et al., 2007), it can be predicted that responders are those patients who 
exhibit, relative to non-responders, a more accentuated decrease in peripheral (RPAW) than total 
apparent airway resistance (RAPP) with increasing lung volume; in these patients a RPAW/RAPP<1, 
which implies a substantial density dependent component of RAPP, should be, therefore, reached at 
EELV levels that still permit adequate exercise VT’s, otherwise impracticable or too expensive in 
terms of elastic work for non-responders. If this were the case, differences between responders and 
non-responders would concern the volume dependence of both peripheral and central airway 
resistance, as determined by the intrinsic mechanical characteristics of the airways, bronchomotor 
tone, oedema of airway walls, secretions, and lung recoil. Because of the many factors involved and 
their complicated interplay, a more complete set of common functional tests at rest and a much 
larger sample of both responders and non-responders are needed to distinguish between the two 
types of COPD patients. 
Bronchodilators have no effect on lung volumes and breathing pattern in non flow-limited 
COPD patients (Tantucci et al., 1998; Pecchiari et al., 2004), but increase IC of flow-limited 
patients, both at rest and during exercise (Tantucci et al., 1998; Pecchiari et al., 2004; O’Donnell et 
al., 2007). This systematic increase of IC contrasts with the variability of IC changes observed with 
heliox in flow-limited patients during exercise, further suggesting that, while bronchodilators lower 
both central and peripheral airway resistance, the effectiveness of heliox administration depends on 
the central or peripheral location of the flow-limiting segment. 
Tolerance of COPD patients to incremental or constant load exercise is either unchanged 
(Raimondi et al., 1970; Bradley et al., 1980; Oelberg et al., 1998) or substantially increased by 
heliox administration (Palange et al., 2004; Eves et al., 2006; Laude et al., 2006). In the present 
patients, an indirect evaluation of this effect would be provided by the changes in the sensation of 
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breathlessness, if the latter becomes a limiting factor of exercise performance (Younes, 1991; Tong 
et al., 2004; O’Donnell et al., 2007). Indeed, heliox lessened the dyspnea both in the present patients 
during non-fatiguing exercises (Table 6) and in those who were performing endurance tests 
(Palange et al., 2004; Eves et al., 2006). However, reduction of dyspnea is not necessarily related to 
changes of respiratory variables, because in COPD patients heliox has no effect on breathing pattern 
and may (Palange et al., 2004; Eves et al., 2006) or may not affect dynamic hyperinflation (Table 
6), while in normal subjects dyspnea perception is unaffected by heliox, in spite of changes in 
breathing pattern and end-expiratory lung volume (Babb, 1997a; 1997b; 2001; McClaran et al., 
1999). Improved respiratory sensation and exercise performance with heliox could be related to 
inspiratory work, which can decrease up to 50-60% even at fixed EELV and breathing pattern, 
depending on the extent of turbulent flow and airway resistance on air (Papamoschou, 1995; 
Brighenti et al., 2007).  
In summary, this study has shown that: a) the breathing pattern, which at rest is similar in 
patients with and without TEFL, differs between the two groups up to 2/3 maximal oxygen 
consumption, with greater VT and V I, paralleled by increased IC in non flow-limited patients and 
decreased IC in flow-limited patients; b) both at rest and during exercise, heliox administration does 
not prevent TEFL, has no effect on the breathing pattern and lung volumes independent of TEFL, 
but lessens exercise dyspnea in all patients; and c) the capability of heliox breathing to increase IC 
during exercise observed in previous studies and in some of the present flow-limited patients, 
should depend on the amount of the upward shift in operating lung volumes while breathing air and 
the associated displacement of the flow-limiting segment from the peripheral to the central airways. 
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Table 1 Anthropometric and routine lung function data of COPD patients with and without tidal 







N  13  13  
Age, yr  69±7  65±7 n.s. 
Height, cm 169±8  165±10 n.s. 
Weight, kg  75±9   72±10 n.s. 
BMI, kgm-2 26.2±2.3  26.4±3.4 n.s. 
MRC scale 2.2±1  1.8±1 n.s. 
TLC, % pred. 111±18  110±14 n.s. 
FRC, % pred. 158±22 135±25 0.020 
IC, % pred.  56±19  80±22 0.001 
FVC, % pred.  75±15  86±11 0.035 
FEV1, % pred.  49±12 64±9 0.003 
FEV1/FVC % 51±6  59±10 0.016 
PEF, % pred.  50±16 77±11 <0.001 
 
Values are mean±SD. TEFL: tidal expiratory flow-limitation; N: number of patients; BMI: body 
mass index; TLC: total lung capacity; FRC: functional residual capacity; IC: inspiratory capacity; 
FVC: forced vital capacity; FEV1: forced expired volume in one second; PEF: peak expiratory flow. 
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Table 2 – Breathing pattern and arterial blood gasses and pH in COPD patients with and without 
tidal expiratory flow-limitation while breathing ambient air at rest 
 
 TEFL no TEFL 
 
N 13 13 
VT, L 0.67±0.25 0.76±0.24 
TI, s 1.24±0.23 1.40±0.25 
TE, s 2.82±0.33 3.11±0.6 
VT/TI, Ls-1 0.54±0.15 0.56±0.2 
VT/TE, Ls-1 0.24±0.07 0.25±0.1 
V I, Lmin-1 9.8±2.8 10.5±3.9 
f, min-1 15.0±2.1 13.7±2.5 
pHa 7.40±0.03 7.41±0.02 
PaO2, mm Hg 81±9 80±5 
PaCO2, mm Hg 40.4±2.9 39.8±2.8 
 
Values are mean±SD. TEFL: tidal expiratory flow-limitation; N: number of patients; VT: tidal 
volume; TI and TE: inspiratory and expiratory duration; V I: pulmonary ventilation; f: breathing 
frequency. 
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Table 3 – Spearman’s correlation coefficients (rs) of chronic dyspnea and tidal expiratory flow-
limitation to resting respiratory variables 
 
 MRC score  TEFL 
 rs P 
 rs P 
IC, % pred. -0.525 0.006 
 
-0.663 <0.001 
FEV1/FVC, % -0.401 0.042 
 
-0.507 0.008 
FEV1, % pred.   
 
-0.640 <0.001 
FRC, % pred.   
 
  0.501 0.009 
 
See Table 1 for definition of abbreviations. 
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Table 4 – Changes of ventilatory pattern and perceived breathlessness while breathing air at two 
work intensities in COPD patients with and without tidal expiratory flow-limitation 
 
 1/3 W max  2/3 W max  
 TEFL no TEFL P TEFL no TEFL P 
N 17 9  20 6  
ΔVT, L  0.24±0.15  0.38±0.21 n.s.   0.40±0.21 0.75±0.22 0.007 
ΔTI, s -0.31±0.31 -0.21±0.18 n.s. -0.45±0.29 -0.39±0.23 n.s. 
ΔTE, s -0.89±0.31 -0.99±0.45 n.s. -1.55±0.38 -1.88±0.51 n.s. 
ΔVT/TI, Ls-1  0.43±0.22  0.43±0.11 n.s.  0.82±0.38  0.84±0.24 n.s. 
ΔVT/TE, Ls-1  0.22±0.08  0.31±0.07 0.010  0.59±0.21  0.86±0.15 0.003 
Δ V I, Lmin-1  8.8±3.4 11.0±2.4 n.s. 20.8±7.7 27.1±4.8 0.032 
Δf, min-1  5.8±2.7 4.7±2.3 n.s. 13.9±4.7 11.8±3.5 n.s 
 ΔIC, L -0.12±0.17 0.17±0.21 0.001  -0.23±0.22   0.13±0.07 0.001 
ΔBorg scale  0.9±1.1 0.8±1.1 n.s. 5.2±2.2   3.9±1.1 0.046 
 




Table 5 – Changes of ventilatory pattern and perceived breathlessness while breathing heliox at two 
work intensities in COPD patients with and without tidal expiratory flow-limitation 
 
 1/3 W max  2/3 W max  
 TEFL no TEFL P TEFL no TEFL P 
N 17 9  20 6  
ΔVT, L  0.28±0.13  0.41±0.24 n.s.   0.42±0.22 0.68±0.18 0.012 
ΔTI, s -0.28±0.23 -0.09±0.31 n.s. -0.42±0.27 -0.17±0.44 n.s. 
ΔTE, s -0.85±0.33 -0.52±0.58 n.s. -1.62±0.41 -1.38±0.33 n.s. 
ΔVT/TI, Ls-1  0.48±0.24  0.40±0.23 n.s.   0.85±0.38   0.72±0.26 n.s. 
ΔVT/TE, Ls-1  0.23±0.10  0.28±0.13 n.s.   0.64±0.27   0.83±0.16 n.s. 
Δ V I, Lmin-1  9.3±4.2 10.2±5.0 n.s.  21.3±4.3  24.9±1.6 0.049 
Δf, min-1  5.6±2.4 3.3±3.2 n.s.  14.6±5.3     9.8±5.5 n.s 
 ΔIC, L -0.11±0.19 0.14±0.21 0.008  -0.22±0.23    0.06±0.18 0.01 
ΔBorg scale  0.4±0.9 0.5±0.9 n.s.   3.2±1.4    1.8±0.7 0.043 
 
Values are mean ±SD. W : work rate; IC: inspiratory capacity.  See Table 2 for definition of 
abbreviations. 
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Table 6 – Changes in ventilatory pattern and perceived breathlessness (Borg scale) shifting from air 




rest  1/3 W max  2/3 W max 
 TEFL no TEFL  TEFL no TEFL  TEFL no TEFL 
N 13 13  17 9  20 6 
ΔVT, L  0.03±0.14 0.01±0.18  0.02±0.08 0.08±0.16  0.02±0.07 0.02±0.04 
ΔTI, s -0.01±0.28 -0.16±0.24  -0.04±0.08 -0.03±0.16  -0.02±0.05 0.02±0.07 
ΔTE, s  0.11±0.40 -0.28±0.56  0.02±0.21 0.07±0.49  -0.02±0.19 -0.04±0.15 
ΔVT/TI, Ls-1  0.04±0.13 0.08±0.13  0.08±0.14 0.08±0.11  0.07±0.12 0.0±0.1 
ΔVT/TE, Ls-1  0.00±0.04 0.03±0.07  0.01±0.06 0.02±0.09  0.05±0.16 0.05±0.13 
Δ V I, Lmin-1  0.3±1.8 1.3±2.6  0.8±2.4 1.1±2.7  1.6±3.9 1.0±2.4 
Δf, min-1 -0.4±2.5 1.4±2.2  0.3±1.8 0.3±2.2  0.7±2.8 0.3±1.9 
ΔIC, L  0.07±0.05 0.04±0.11  0.09±0.10 0.01±0.14  0.05±0.07 0.03±0.14 
Δ Borg scale  0 0  -0.5±1.3 -0.3±0.9   -2.1±1.8*  -1.2±0.7* 
 
Values are mean±SD. W : work rate; IC: inspiratory capacity.  See Table 2 for definition of 





Fig. 1. End-expiratory and end-inspiratory lung volumes as a function of work rate in COPD 
patients who were always expiratory flow-limited (n=13) or non flow-limited (n=6) while breathing 
ambient air or heliox, and in all COPD patients (n=26) while breathing ambient air or heliox. 
Fig. 2. Changes in inspiratory capacity (IC) between heliox and air breathing during exercise as a 
function of the corresponding changes in IC between rest and exercise while breathing ambient air 
in COPD patients with (closed symbols) or without tidal expiratory flow-limitation (open symbols). 
Continuous and dashed lines are linear regression through data pertaining to flow-limited and non 
flow-limited patients, respectively. Values refer to the regression obtained for the flow-limited 
patients. 
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